ADA and severe combined immunodeficiency: Approval of gene therapy for Adenosine Deaminase (ADA) deficient severe combined immunodeficiency (SCID) occurred 25 years after the first gene therapy attempt to treat children affected bythis disorder, also known as bubble babies20.